
LQDA Stock Forecast & Price Target
LQDA Analyst Ratings
Bulls say
Liquidia is well positioned for future success with a robust and diversifying pipeline, continued positive clinical results and strong financials, including a recent increase in cash. The company's proprietary PRINT technology is a strong differentiator in a crowded market, and the expansion of their product line into a variety of indications provides multiple avenues for growth. While there may be some legal risks related to current lawsuits, the overall outlook for Liquidia and its stock remains positive.
Bears say
Liquidia is showing impressive sales momentum and exciting developments with their product Yutrepia, but there are risks to consider. The company will face increasing competition, their financials may require a secondary offering, and the ongoing legal battle surrounding their patents could hinder their success.
This aggregate rating is based on analysts' research of Liquidia Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
LQDA Analyst Forecast & Price Prediction
Start investing in LQDA
Order type
Buy in
Order amount
Est. shares
0 shares